{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:42:17Z","timestamp":1785177737347,"version":"3.55.0"},"reference-count":129,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liraglutide is a GLP-1 analog (glucagon like peptide-1) used primarily in the treatment of diabetes mellitus type 2 (DM2) and obesity. The literature starts to suggest that liraglutide may reduce the effects of ischemic stroke by activating anti-apoptotic pathways, as well as limiting the harmful effects of free radicals. The GLP-1R expression has been reported in the cerebral cortex, especially occipital and frontal lobes, the hypothalamus, and the thalamus. Liraglutide reduced the area of ischemia caused by MCAO (middle cerebral artery occlusion), limited neurological deficits, decreased hyperglycemia caused by stress, and presented anti-apoptotic effects by increasing the expression of Bcl-2 and Bcl-xl proteins and reduction of Bax and Bad protein expression. The pharmaceutical managed to decrease concentrations of proapoptotic factors, such as NF-\u03baB (Nuclear Factor-kappa \u03b2), ICAM-1 (Intercellular Adhesion Molecule 1), caspase-3, and reduced the level of TUNEL-positive cells. Liraglutide was able to reduce the level of free radicals by decreasing the level of malondialdehyde (MDA), and increasing the superoxide dismutase level (SOD), glutathione (GSH), and catalase. Liraglutide may affect the neurovascular unit causing its remodeling, which seems to be crucial for recovery after stroke. Liraglutide may stabilize atherosclerotic plaque, as well as counteract its early formation and further development. Liraglutide, through its binding to GLP-1R (glucagon like peptide-1 receptor) and consequent activation of PI3K\/MAPK (Phosphoinositide 3-kinase\/mitogen associated protein kinase) dependent pathways, may have a positive impact on A\u03b2 (amyloid beta) trafficking and clearance by increasing the presence of A\u03b2 transporters in cerebrospinal fluid. Liraglutide seems to affect tau pathology. It is possible that liraglutide may have some stem cell stimulating properties. The effects may be connected with PKA (phosphorylase kinase A) activation. This paper presents potential mechanisms of liraglutide activity in conditions connected with neuronal damage, with special emphasis on Alzheimer\u2019s disease and cerebral ischemia.<\/jats:p>","DOI":"10.3390\/ijms20051050","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T03:29:21Z","timestamp":1551410961000},"page":"1050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Liraglutide and its Neuroprotective Properties\u2014Focus on Possible Biochemical Mechanisms in Alzheimer\u2019s Disease and Cerebral Ischemic Events"],"prefix":"10.3390","volume":"20","author":[{"given":"Micha\u0142","family":"Wici\u0144ski","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3327-3334","authenticated-orcid":false,"given":"Maciej","family":"Socha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Gynecological Oncology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Ujejskiego 75; 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Malinowski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-3414","authenticated-orcid":false,"given":"Eryk","family":"W\u00f3dkiewicz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-1330","authenticated-orcid":false,"given":"Maciej","family":"Walczak","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-9403","authenticated-orcid":false,"given":"Karol","family":"G\u00f3rski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"S\u0142upski","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and General Surgery. Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pawlak-Osi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Gynecological Oncology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Ujejskiego 75; 85-168 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2016). Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000\u20132015 [Internet], World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Goldstein, B.J., and M\u00fcller-Wieland, D. (2016). Type 2 Diabetes: Principles and Practice, CRC Press.","DOI":"10.3109\/9780849379581"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.physbeh.2006.05.048","article-title":"Gastrointestinal satiety signals in humans\u2014Physiologic roles for GLP-1 and PYY?","volume":"89","author":"Beglinger","year":"2006","journal-title":"Physiol. Behav."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/dc08-1355","article-title":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: The LEAD (liraglutide effect and action in diabetes)-2 study","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15suppl1-09","article-title":"Liraglutide for the treatment of type 2 diabetes: A single technology appraisal","volume":"15","author":"Shyangdan","year":"2011","journal-title":"Health Technol. Assess."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hunter, K., and H\u00f6lscher, C. (2012). Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. Bmc Neurosci., 13.","DOI":"10.1186\/1471-2202-13-33"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/0091270009354996","article-title":"Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide","volume":"50","author":"Watson","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/1389450043345245","article-title":"A new Alzheimer\u2019s disease interventive strategy: GLP-1","volume":"5","author":"Perry","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?","volume":"118","author":"Bassil","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0305-0491(98)10163-3","article-title":"Insulin, insulin-like growth factor-I (IGF-I) and glucagon: The evolution of their receptors","volume":"122","author":"Navarro","year":"1999","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13813450801900694","article-title":"Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways","volume":"114","author":"Werner","year":"2008","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward a comprehensive neurobiology of IGF-I","volume":"70","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Duarte, A.I., Moreira, P.I., and Oliveira, C.R. (2012). Insulin in central nervous system: More than just a peripheral hormone. J. Aging Res., 2012.","DOI":"10.1155\/2012\/384017"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/er.2007-0031","article-title":"Targeting \u03b2-Cell mass in type 2 diabetes: Promise and limitations of new drugs based on incretins","volume":"29","author":"Salehi","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/endo.142.5.8128","article-title":"Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic \u03b2-cells by a cyclic adenosine monophosphate\/protein kinase A-dependent mechanism","volume":"142","author":"Wang","year":"2001","journal-title":"Endocrinology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32814","DOI":"10.1074\/jbc.M104738200","article-title":"Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase\/Akt-mediated mechanism that reduces the activation of caspase-3","volume":"276","author":"Barber","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molbrainres.2005.03.004","article-title":"Inhibition of GSK3\u03b2 is a common event in neuroprotection by different survival factors","volume":"137","author":"Chin","year":"2005","journal-title":"Mol. Brain Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dupraz, S., Grassi, D., Karnas, D., Guil, A.F.N., Hicks, D., and Quiroga, S. (2013). The insulin-like growth factor 1 receptor is essential for axonal regeneration in adult central nervous system neurons. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054462"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"42142","DOI":"10.1074\/jbc.M507607200","article-title":"Nutritional status, cognition and survival-a new role for leptin and AMPK","volume":"280","author":"Dagon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2014.09.064","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia","volume":"281","author":"Briyal","year":"2014","journal-title":"Neuroscience"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNR.0000000000000490","article-title":"A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat","volume":"27","author":"Han","year":"2016","journal-title":"Neuroreport"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.3390\/ijms141121513","article-title":"Neuroprotective effects of liraglutide for stroke model of rats","volume":"14","author":"Sato","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26859","DOI":"10.1038\/srep26859","article-title":"The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K\/AKT and MAPK pathways","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1262\/jrd.20250","article-title":"Relationship between caspase activity and apoptotic markers in human sperm in response to hydrogen peroxide and progesterone","volume":"55","author":"Lozano","year":"2009","journal-title":"J. Reprod. Dev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2017.01.045","article-title":"Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats","volume":"641","author":"Dong","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-7378-2-13","article-title":"Functional assessments in the rodent stroke model","volume":"2","author":"Schaar","year":"2010","journal-title":"Exp. Transl. Stroke Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: Key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1179\/1743132812Y.0000000019","article-title":"Injury and repair in the neurovascular unit","volume":"34","author":"Xing","year":"2012","journal-title":"Neurol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arr.2016.09.006","article-title":"Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect","volume":"34","author":"Cai","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Li, P.C., Liu, L.F., Jou, M.J., and Wang, H.K. (2016). The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice. BMC Neurosci., 17.","DOI":"10.1186\/s12868-016-0272-9"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2011.12.039","article-title":"The glucagon-like peptide 1 analog liraglutide reduces TNF-\u03b1-induced oxidative stress and inflammation in endothelial cells","volume":"221","author":"Shiraki","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3094504","DOI":"10.1155\/2018\/3094504","article-title":"Liraglutide Activates the Nrf2\/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats","volume":"2018","author":"Deng","year":"2018","journal-title":"Comput. Intell. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuint.2016.09.004","article-title":"Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells","volume":"106","author":"Zagoura","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2016.04.045","article-title":"Nrf2\/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning","volume":"309","author":"Xue","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1590\/S0102-865020150060000008","article-title":"Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2\/HO-1 pathway","volume":"30","author":"Jiang","year":"2015","journal-title":"Acta Cir. Bras."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1089\/ars.2011.4498","article-title":"Oxygen consumption and usage during physical exercise: The balance between oxidative stress and ROS-dependent adaptive signaling","volume":"18","author":"Radak","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1074\/jbc.M111.312694","article-title":"Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis","volume":"287","author":"Niture","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Szadujkis-Szadurska, K., Malinowski, B., Piotrowska, M., Grze\u015bk, G., Wici\u0144ski, M., and Gajdus, M. (2016). The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions. Biomed Res. Int., 2016.","DOI":"10.1155\/2016\/3679048"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"29296","DOI":"10.1074\/jbc.M702853200","article-title":"Glutathione binding to the Bcl-2 homology-3 domain groove: A molecular basis for Bcl-2 antioxidant function at mitochondria","volume":"282","author":"Zimmermann","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_45","first-page":"541","article-title":"Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: Implications for breast cancer cell survival","volume":"37","author":"Bratton","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12031-008-9122-2","article-title":"Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate","volume":"37","author":"Creson","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2009.05.024","article-title":"ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells","volume":"47","author":"Cao","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0891-5849(03)00318-6","article-title":"T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation","volume":"35","author":"Kwon","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jcb.24763","article-title":"Protective action of liraglutide in beta cells under lipotoxic stress via PI3K\/Akt\/FoxO1 pathway","volume":"115","author":"Shao","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"ref_50","first-page":"1221","article-title":"Liraglutide promotes proliferation and migration of cardiac microvascular endothelial cells through PI3K\/Akt and MAPK\/ERK signaling pathways","volume":"35","author":"Zhang","year":"2015","journal-title":"J. South. Med. Univ."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/bpb.b14-00505","article-title":"The glucagon-like peptide-1 analogue liraglutide inhibits oxidative stress and inflammatory response in the liver of rats with diet-induced non-alcoholic fatty liver disease","volume":"38","author":"Gao","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.4238\/2015.December.29.17","article-title":"Glucagon-like peptide-1 receptor agonists inhibit hepatic stellate cell activation by blocking the p38 MAPK signaling pathway","volume":"14","author":"Wu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: Heart disease and stroke statistics-2016 update: A report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e001119","DOI":"10.1161\/JAHA.114.001119","article-title":"Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging","volume":"3","author":"Chung","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1479164113481817","article-title":"The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE\u2212\/\u2212 mouse model","volume":"10","author":"Gaspari","year":"2013","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10557-013-6463-z","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation","volume":"27","author":"Dai","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mvr.2018.05.002","article-title":"The role of Rho-kinase and calcium ions in constriction triggered by ET-1","volume":"119","author":"Malinowski","year":"2018","journal-title":"Microvasc. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wici\u0144ski, M., Socha, M., Walczak, M., W\u00f3dkiewicz, E., Malinowski, B., Rewerski, S., G\u00f3rski, K., and Pawlak-Osi\u0144ska, K. (2018). Beneficial Effects of Resveratrol Administration\u2014Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. Nutrients, 10.","DOI":"10.3390\/nu10111813"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: A marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","article-title":"Inflammation, oxidative stress and renin angiotensin system in atherosclerosis","volume":"6","author":"Husain","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1212\/WNL.0b013e3182695836","article-title":"Role of the vascular endothelium and plaque in acute ischemic stroke","volume":"79","author":"Madden","year":"2012","journal-title":"Neurology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.peptides.2013.12.015","article-title":"A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis","volume":"54","author":"Tashiro","year":"2014","journal-title":"Peptides"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cellbi.2009.02.011","article-title":"Study of the insulin signaling pathways in the regulation of ACAT1 expression in cultured macrophages","volume":"33","author":"Xin","year":"2009","journal-title":"Cell Biol. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of Alzheimer disease","volume":"63","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: The Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2337\/db11-1186","article-title":"Metabolic alterations induced by sucrose intake and Alzheimer\u2019s disease promote similar brain mitochondrial abnormalities","volume":"61","author":"Carvalho","year":"2012","journal-title":"Diabetes"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fattyacid-inducedNLRP3-ASC inflammasome activation interferes with insulin signalling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wici\u0144ski, M., W\u00f3dkiewicz, E., S\u0142upski, M., Walczak, M., Socha, M., Malinowski, B., and Pawlak-Osi\u0144ska, K. (2018). Neuroprotective activity of sitagliptin via reduction of neuroinflammation beyond the incretin effect: Focus on Alzheimer\u2019s disease. Biomed Res. Int., 2018.","DOI":"10.1155\/2018\/6091014"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer\u2019s disease and insulin resistance: Translating basic science into clinical applications","volume":"123","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1229086","DOI":"10.1080\/23312025.2016.1229086","article-title":"The physiological role of the brain GLP-1 system in stress","volume":"2","author":"Holt","year":"2016","journal-title":"Cogent Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1471-4159.2004.02914.x","article-title":"The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem","volume":"92","author":"Alvarez","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity","volume":"9","author":"Kappe","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"ref_81","first-page":"5","article-title":"The impact of dietary energy intake on cognitive aging","volume":"2","author":"Mattson","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"d7771","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials","volume":"344","author":"Christensen","year":"2012","journal-title":"BMJ"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: An emerging opportunity to treat neurodegenerative and cerebrovascular disorders","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_85","first-page":"9202954","article-title":"Resveratrol increases serum BDNF concentrations and reduces vascular smooth muscle cells contractility via a NOS-3-independent mechanism","volume":"2017","author":"Malinowski","year":"2017","journal-title":"Biomed Res. Int."},{"key":"ref_86","first-page":"1","article-title":"A simple role for BDNF in learning and memory?","volume":"3","author":"Cunha","year":"2010","journal-title":"Front. Mol. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14728222.8.5.391","article-title":"Brain-derived neurotrophic factor as a drug target for CNS disorders","volume":"8","author":"Pezet","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","article-title":"The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer\u2019s disease","volume":"490","author":"Carro","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Devi, L., Alldred, M.J., Ginsberg, S.D., and Ohno, M. (2012). Mechanisms underlying insulin deficiency-induced acceleration of \u03b2-amyloidosis in a mouse model of Alzheimer\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032792"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Parthsarathy, V., and H\u00f6lscher, C. (2013). Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058784"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1096\/fj.09-133454","article-title":"Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons","volume":"23","author":"Belsham","year":"2009","journal-title":"FASEB J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.stem.2009.10.003","article-title":"Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer\u2019s disease","volume":"5","author":"Sun","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nn.2185","article-title":"Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain","volume":"11","author":"Imayoshi","year":"2008","journal-title":"Nat. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17501","DOI":"10.1073\/pnas.0607207103","article-title":"Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus","volume":"103","author":"Saxe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Babateen, O., Korol, S.V., Jin, Z., Bhandage, A.K., Ahemaiti, A., and Birnir, B. (2017). Liraglutide modulates GABAergic signaling in rat hippocampal CA3 pyramidal neurons predominantly by presynaptic mechanism. Bmc Pharmacol. Toxicol., 18.","DOI":"10.1186\/s40360-017-0191-0"},{"key":"ref_96","first-page":"752","article-title":"Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures","volume":"16","author":"Gupta","year":"2017","journal-title":"EXCLI J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2003.02073.x","article-title":"Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons","volume":"87","author":"Gilman","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer\u2019s disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2015.12.052","article-title":"The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy","volume":"1634","author":"Hansen","year":"2016","journal-title":"Brain Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuropharm.2018.11.002","article-title":"Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of \u03b2-amyloid pathology","volume":"144","author":"Bencze","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mcn.2015.02.016","article-title":"Current and future implications of basic and translational research on amyloid-\u03b2 peptide production and removal pathways","volume":"66","author":"Bohm","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2014A toxic pas de deux in Alzheimer\u2019s disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.drudis.2006.08.004","article-title":"Clearance of amyloid-beta in Alzheimer\u2019s disease: Progress, problems and perspectives","volume":"11","author":"Wang","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/156720510793499066","article-title":"Blood-brain-barrier models for the investigation of transporter-and receptor-mediated amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"7","author":"Pflanzner","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"BSR20171284","DOI":"10.1042\/BSR20171284","article-title":"GLP-1 receptor regulates cell growth through regulating IDE expression level in A\u03b21\u201342-treated PC12 cells","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Costa, R., Ferreira-da-Silva, F., Saraiva, M.J., and Cardoso, I. (2008). Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002899"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","article-title":"Transthyretin binding to A-Beta peptide\u2013Impact on A-Beta fibrillogenesis and toxicity","volume":"582","author":"Costa","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.neurobiolaging.2005.06.015","article-title":"Therapeutic actions of insulin-like growth factor I on APP\/PS2 mice with severe brain amyloidosis","volume":"27","author":"Carro","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2302\/kjm.55.59","article-title":"Serum insulin-like growth factor I in brain function","volume":"55","author":"Carro","year":"2006","journal-title":"KEIO J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/jcb.26321","article-title":"cAMP\/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer\u2019s disease","volume":"119","author":"Li","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_118","first-page":"152","article-title":"Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer\u2019s disease patients","volume":"24","author":"Padurariu","year":"2012","journal-title":"Psychiatr. Danub."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1750-3639.2002.tb00460.x","article-title":"Caspase-cleaved amyloid precursor protein in Alzheimer\u2019s disease","volume":"12","author":"Ng","year":"2002","journal-title":"Brain Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4236\/aad.2015.43007","article-title":"Activated caspase-3 and neurodegeneration and synaptic plasticity in Alzheimer\u2019s disease","volume":"4","author":"Prendecki","year":"2015","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1471-4159.2007.04942.x","article-title":"Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain","volume":"103","author":"Liang","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.neurobiolaging.2007.12.004","article-title":"Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP\/PKA signalling pathway","volume":"30","author":"Wang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2017.04.005","article-title":"Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation","volume":"103","author":"Eggels","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3233\/JAD-130491","article-title":"Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes","volume":"37","author":"Yang","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jnc.13248","article-title":"Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db\/db mice","volume":"135","author":"Ma","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3\u03b2 pathway in an amyloid \u03b2 protein induced alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:35:18Z","timestamp":1760186118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":129,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20051050"],"URL":"https:\/\/doi.org\/10.3390\/ijms20051050","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}